Axess Vision Technology Ltd
TypePrivately held
IndustryMedical technology
Founded2006
HeadquartersTours
Key people
Regis Olivier, General Manager
ProductsMedical devices
Number of employees
18

Axess Vision Technology is a start-up company and manufacturer of medical devices, mainly endoscopes. It is headquartered in Saint Pierre des Corps, France. It is competing with Ambu and Single Use Surgical Ltd to develop the world first generation of disposable endoscopes.[1] These companies are responding to a market need of getting rid of cross contamination from flexible endoscopes, the latter ranked third in the ECRI 2011 top 10 Health Hazards.[2] Even when endoscopes are spotless, there remains a risk of infection of 1%. Therefore, these endoscopes are designed to be used on one patient only before being incinerated.[3]

Its main investors are the venture capitalists OTC Asset Management and Cap Décisif Management, with 2.5 million euros in the first round.[4][5][6][7] Its main competitors are the German Invendo and the English Single Use Surgical.[8] The problematic decontamination of reusable endoscopes and the risk of nosocomial infections seems to have prompted this race for innovation.[9] Indeed, even if traditional endoscopes are cleaned and decontaminated after use, there is always a risk of infection of about 1%. The endoscopes developed by Axess Vision Technology are therefore designed to be used once before being incinerated.[10][11]

In 2014, a contract was signed with the University Hospital of Rennes.[12]

On February 7, 2017, the company was placed in safeguard proceedings.[13]

See also

References

  1. ↑ Brosky, John (2009). "Three EU companies vying to launch single use endoscope". Medical Device Daily. 13.
  2. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2011-07-24. Retrieved 2011-04-20.{{cite web}}: CS1 maint: archived copy as title (link)
  3. ↑ "100 start up où investir santé et biologie". Challenges (256). 2011. Retrieved 2011-05-13.
  4. ↑ Axess Vision Technology lève 2,5 M€ auprès d'OTC Asset Management et de Cap Decisif Management, Paris le 28 octobre 2008
  5. ↑ Portfolio: Life Sciences - Medical Devices, Cap Decisif Management
  6. ↑ Cap Decisif 2, CDC Entreprises
  7. ↑ R, J (24 November 2008). "L'endoscope d'AVT recueille €2,5 M". Capital Finance (in French) (908): 3.
  8. ↑ Brosky, John (16 January 2009). "Three EU companies vying to launch single use endoscope". Medical Device Daily. 13.
  9. ↑ Gamble, HP (2007). "Endoscope decontamination incidents in England 2003-2004". J Hosp Infect. 4 (67): 350–354. doi:10.1016/j.jhin.2007.08.017. PMID 18023923.
  10. ↑ "Santé et Biotechnologies". Challenges (in French) (256). 12 May 2011. Retrieved 13 May 2011.
  11. ↑ "Avec son endoscope jetable Axess Vision voit loin". lanouvellerepublique.fr. January 26, 2016. Retrieved 2019-02-15.
  12. ↑ "Succès de l'endoscope jetable d'Axess Vision". Les Echos (in French). 2014-12-26. Retrieved 2022-07-22.
  13. ↑ "AXESS VISION TECHNOLOGY (JOUE-LES-TOURS) Chiffre d'affaires, résultat, bilans sur SOCIETE.COM - 488295759". www.societe.com. Retrieved 2022-07-22.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.